human papilloma viruslik partial hp lp serv base current license vaccine previous shown encased dna express model antigen mm respiratory syncyti virus rev pseudovirion psv immunogen deli intravagin caps confer trois basal epithelium metres attract carrier vaccine target skin use microneedl studi ask whether admins could induce protect immune response psvencapsid plasmid elicit transfer mouse immune coat genre robust neutral antibody protect challenge microneedl array hmm have protein gene test dosedepend specify detect postimmun mmspecif cell post respect psv full reduce viral load lung nose upon entrants summary induce prime antigen encode encased although immunogen common dose response threshold hpvspecif immune taken together data suggest delivery dyphil provide practice thermost combine vaccine approach develop clinic value 